The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31994845.
- Also identified by DOI 10.1002/adhm.201901410 and PMC identifier 7274859.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Powerful experimental tools have contributed a wealth of novel insight into cancer etiology from the organ to the subcellular levels. However, these advances in understanding have outpaced improvements in clinical outcomes. One possible reason for this shortcoming is the reliance on animal models that do not fully replicate human physiology. An alternative in vitro approach that has recently emerged features engineered microfluidic platforms to investigate cancer progression. These devices allow precise control over cellular components, extracellular constituents, and physical forces, while facilitating detailed microscopic analysis of the metastatic process. This review focuses on the recent use of microfluidic platforms to investigate the mechanism of cancer cell extravasation.
Medical subject headings
- Microfluidics
- Neoplasms